Additional Papers

Possible Drug Candidates for COVID-19

A Trial of Lopinavir – Ritonavir in Adults Hospitalized with Severe COVID-19

Deja Vu:  Stimulating Open Drug Discovery for SARS-CoV-2

Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface

The inhales corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15

Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential

Discovering drugs to treat coronavirus disease 2019 (COVID-2019)

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

Potential Therapeutic Agents for COVID-19 Based on the Analysis of Protease and RNA Polymerase Docking

Old Drugs for Newly Emerging Viral Disease, COVID-19: Bioinformatic Prospective

Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model

Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Kore identified potential therapeutic option for COVID-19

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s